作者: Gary M. Freedman , Barbara L. Fowble
DOI:
关键词:
摘要: Approximately 10% to 15% of patients with stage I/II invasive breast cancer will develop a clinically isolated local recurrence. The standard management an ipsilateral tumor recurrence following breast-